Pretarget radiotherapy with an anti-CD25 antibody-streptavidin fusion protein was effective in therapy of leukemia/lymphoma xenografts.

Source:http://linkedlifedata.com/resource/pubmed/id/12569172

Proc. Natl. Acad. Sci. U.S.A. 2003 Feb 18 100 4 1891-5

Download in:

View as

Triples

General Info

PMID
12569172